1. Home
  2. TSLX vs EVO Comparison

TSLX vs EVO Comparison

Compare TSLX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.71

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.68

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
EVO
Founded
2010
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
934.1M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
TSLX
EVO
Price
$17.71
$2.68
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$21.61
$7.00
AVG Volume (30 Days)
763.2K
94.1K
Earning Date
05-05-2026
04-08-2026
Dividend Yield
10.82%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
$1.20
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.99
$2.31
52 Week High
$25.17
$4.80

Technical Indicators

Market Signals
Indicator
TSLX
EVO
Relative Strength Index (RSI) 41.95 36.25
Support Level $17.25 $2.32
Resistance Level $18.65 $3.78
Average True Range (ATR) 0.50 0.09
MACD -0.16 -0.06
Stochastic Oscillator 16.86 6.44

Price Performance

Historical Comparison
TSLX
EVO

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: